Advisors Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.28M | Buy |
28,481
+1,000
| +4% | +$82.4K | 0.04% | 557 |
|
|
2025
Q4 | $2.34M | Buy |
27,481
+9,598
| +54% | +$788K | 0.04% | 551 |
|
|
2025
Q3 | $1.39M | Buy |
17,883
+1,727
| +11% | +$135K | 0.02% | 701 |
|
|
2025
Q2 | $1.26M | Sell |
16,156
-559
| -3% | -$41.7K | 0.02% | 702 |
|
|
2025
Q1 | $1.21M | Buy |
16,715
+469
| +3% | +$33.6K | 0.02% | 700 |
|
|
2024
Q4 | $1.2M | Buy |
16,246
+4,390
| +37% | +$307K | 0.02% | 699 |
|
|
2024
Q3 | $782K | Buy |
11,856
+852
| +8% | +$61.9K | 0.01% | 796 |
|
|
2024
Q2 | $1.02M | Sell |
11,004
-3,083
| -22% | -$273K | 0.02% | 720 |
|
|
2024
Q1 | $1.35M | Sell |
14,087
-155
| -1% | -$13K | 0.03% | 664 |
|
|
2023
Q4 | $1.09M | Sell |
14,242
-6,359
| -31% | -$442K | 0.02% | 705 |
|
|
2023
Q3 | $1.43M | Buy |
20,601
+781
| +4% | +$62.8K | 0.03% | 601 |
|
|
2023
Q2 | $1.87M | Sell |
19,820
-3,488
| -15% | -$303K | 0.04% | 532 |
|
|
2023
Q1 | $1.93M | Sell |
23,308
-599
| -3% | -$47.1K | 0.04% | 534 |
|
|
2022
Q4 | $1.78M | Sell |
23,907
-11,052
| -32% | -$852K | 0.04% | 538 |
|
|
2022
Q3 | $2.89M | Buy |
34,959
+373
| +1% | +$35.9K | 0.06% | 371 |
|
|
2022
Q2 | $3.29M | Sell |
34,586
-8,970
| -21% | -$929K | 0.06% | 342 |
|
|
2022
Q1 | $5.13M | Buy |
43,556
+117
| +0.3% | +$13.1K | 0.08% | 267 |
|
|
2021
Q4 | $5.63M | Sell |
43,439
-13,186
| -23% | -$1.54M | 0.08% | 256 |
|
|
2021
Q3 | $6.41M | Buy |
+56,625
| New | +$6.46M | 0.1% | 204 |
|
|
2021
Q2 | – | Sell |
-55,845
| Closed | -$4.67M | – | 1434 |
|
|
2021
Q1 | $4.67M | Sell |
55,845
-4,740
| -8% | -$401K | 0.07% | 271 |
|
|
2020
Q4 | $5.53M | Sell |
60,585
-6,641
| -10% | -$551K | 0.09% | 214 |
|
|
2020
Q3 | $5.37M | Buy |
67,226
+1,076
| +2% | +$84K | 0.1% | 185 |
|
|
2020
Q2 | $4.57M | Sell |
66,150
-10,521
| -14% | -$748K | 0.09% | 221 |
|
|
2020
Q1 | $4.82M | Sell |
76,671
-8,109
| -10% | -$585K | 0.11% | 176 |
|
|
2019
Q4 | $6.59M | Sell |
84,780
-1,002
| -1% | -$78.2K | 0.12% | 204 |
|
|
2019
Q3 | $6.29M | Sell |
85,782
-2,796
| -3% | -$196K | 0.12% | 203 |
|
|
2019
Q2 | $5.46M | Sell |
88,578
-15,057
| -15% | -$910K | 0.1% | 247 |
|
|
2019
Q1 | $6.61M | Buy |
103,635
+12,204
| +13% | +$696K | 0.12% | 199 |
|
|
2018
Q4 | $4.67M | Buy |
91,431
+3,930
| +4% | +$199K | 0.09% | 248 |
|
|
2018
Q3 | $5.08M | Buy |
87,501
+3,861
| +5% | +$189K | 0.08% | 291 |
|
|
2018
Q2 | $4.06M | Buy |
83,640
+17,175
| +26% | +$802K | 0.07% | 347 |
|
|
2018
Q1 | $2.96M | Sell |
66,465
-20,217
| -23% | -$878K | 0.05% | 479 |
|
|
2017
Q4 | $3.26M | Sell |
86,682
-14,508
| -14% | -$532K | 0.05% | 455 |
|
|
2017
Q3 | $3.69M | Sell |
101,190
-20,487
| -17% | -$781K | 0.06% | 428 |
|
|
2017
Q2 | $4.8M | Sell |
121,677
-21,669
| -15% | -$791K | 0.08% | 342 |
|
|
2017
Q1 | $4.5M | Sell |
143,346
-101,643
| -41% | -$3.18M | 0.08% | 364 |
|
|
2016
Q4 | $7.65M | Sell |
244,989
-22,104
| -8% | -$716K | 0.13% | 231 |
|
|
2016
Q3 | $10.7M | Sell |
267,093
-33,075
| -11% | -$1.25M | 0.18% | 153 |
|
|
2016
Q2 | $9.98M | Sell |
300,168
-25,818
| -8% | -$883K | 0.16% | 177 |
|
|
2016
Q1 | $9.59M | Buy |
325,986
+41,988
| +15% | +$1.16M | 0.16% | 184 |
|
|
2015
Q4 | $7.48M | Buy |
283,998
+81,192
| +40% | +$2.11M | 0.12% | 243 |
|
|
2015
Q3 | $4.8M | Buy |
202,806
+43,914
| +28% | +$1.06M | 0.08% | 357 |
|
|
2015
Q2 | $3.77M | Buy |
158,892
+28,860
| +22% | +$651K | 0.05% | 475 |
|
|
2015
Q1 | $3.09M | Buy |
130,032
+37,962
| +41% | +$852K | 0.04% | 513 |
|
|
2014
Q4 | $1.96M | Buy |
92,070
+43,074
| +88% | +$865K | 0.03% | 651 |
|
|
2014
Q3 | $834K | Buy |
48,996
+3,582
| +8% | +$56.5K | 0.01% | 855 |
|
|
2014
Q2 | $650K | Sell |
45,414
-6,240
| -12% | -$84.6K | 0.01% | 951 |
|
|
2014
Q1 | $639K | Sell |
51,654
-6,258
| -11% | -$72.2K | 0.01% | 908 |
|
|
2013
Q4 | $635K | Sell |
57,912
-7,734
| -12% | -$87.2K | 0.01% | 895 |
|
|
2013
Q3 | $762K | Buy |
65,646
+1,782
| +3% | +$20.8K | 0.01% | 760 |
|
|
2013
Q2 | $715K | Buy |
+63,864
| New | +$756K | 0.01% | 731 |
|
Other funds holding EW
VCM
VPM
Advisors Asset Management's EW Position: Q1 2026 in Review
Advisors Asset Management increased its Edwards Lifesciences (EW) stake by 3.6% in Q1 2026, buying an estimated $82.4K and bringing the position to 28,481 shares worth $2.28M. The position accounts for 0.04% of the portfolio, ranked #557.
Advisors Asset Management first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $10.7M in Q3 2016. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Advisors Asset Management held 28,481 shares of Edwards Lifesciences worth $2.28M as of Q1 2026.
- Advisors Asset Management bought 1,000 Edwards Lifesciences shares in Q1 2026, an estimated $82.4K.
- Edwards Lifesciences made up 0.04% of Advisors Asset Management's portfolio in Q1 2026, its #557 holding.
- Advisors Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Advisors Asset Management's Edwards Lifesciences position peaked at $10.7M in Q3 2016.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.